X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (765) 765
Publication (105) 105
Book Review (7) 7
Book Chapter (5) 5
Book / eBook (2) 2
Dissertation (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (453) 453
index medicus (440) 440
iii beta-tubulin (365) 365
oncology (272) 272
animals (210) 210
female (210) 210
tubulin - metabolism (182) 182
chemotherapy (178) 178
cancer (168) 168
expression (168) 168
male (165) 165
middle aged (126) 126
paclitaxel (124) 124
aged (119) 119
immunohistochemistry (105) 105
cell biology (103) 103
tubulin (103) 103
adult (100) 100
prognosis (99) 99
neurosciences (94) 94
biochemistry & molecular biology (93) 93
cell line, tumor (93) 93
mice (90) 90
research (88) 88
resistance (87) 87
cell lung-cancer (84) 84
microtubules (80) 80
proteins (79) 79
tubulin - genetics (78) 78
tubulins (76) 76
class iii beta-tubulin (75) 75
article (70) 70
class iii β-tubulin (70) 70
in-vitro (70) 70
survival (70) 70
analysis (69) 69
gene expression (69) 69
pharmacology & pharmacy (67) 67
antineoplastic agents - pharmacology (65) 65
drug resistance, neoplasm (64) 64
breast-cancer (63) 63
lung neoplasms - drug therapy (63) 63
research article (62) 62
care and treatment (60) 60
carcinoma, non-small-cell lung - drug therapy (59) 59
antineoplastic agents - therapeutic use (56) 56
pathology (56) 56
tumors (56) 56
docetaxel (55) 55
cells (53) 53
genetic aspects (53) 53
paclitaxel resistance (53) 53
drug resistance (52) 52
lung cancer (52) 52
metastasis (51) 51
apoptosis (50) 50
antineoplastic combined chemotherapy protocols - therapeutic use (49) 49
medicine (49) 49
health aspects (48) 48
microtubules - metabolism (48) 48
treatment outcome (48) 48
aged, 80 and over (47) 47
biomarkers (47) 47
breast cancer (47) 47
ercc1 (46) 46
mutation (46) 46
beta-tubulin (45) 45
cancer therapies (45) 45
cisplatin (44) 44
taxol (44) 44
neoplasm staging (43) 43
carcinoma (42) 42
gene-expression (42) 42
lung neoplasms - pathology (42) 42
neurons (42) 42
physiological aspects (42) 42
biology (41) 41
gene expression regulation, neoplastic (41) 41
multidisciplinary sciences (41) 41
paclitaxel - pharmacology (41) 41
rats (41) 41
cells, cultured (40) 40
chemistry, medicinal (40) 40
differentiation (40) 40
lung cancer, non-small cell (40) 40
phase-iii trial (40) 40
biomarkers, tumor - metabolism (39) 39
science (38) 38
carcinoma, non-small-cell lung - pathology (37) 37
disease-free survival (37) 37
messenger-rna expression (37) 37
cancer research (36) 36
phase-iii (36) 36
tubulin - biosynthesis (36) 36
antineoplastic agents (35) 35
hematology, oncology and palliative medicine (35) 35
sensitivity (35) 35
adjuvant chemotherapy (34) 34
medicine & public health (34) 34
microtubules - drug effects (34) 34
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 11/2010, Volume 70, Issue 22, pp. 9253 - 9264
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2016, Volume 113, Issue 40, pp. 11294 - 11299
There are seven β-tubulin isotypes present in distinct quantities in mammalian cells of different origin. Altered expression of β-tubulin isotypes has been... 
Tubulin isotypes | Photolabeling | Taxol | Drug binding | Microtubule stabilizing agents | MICROTUBULE STABILIZATION | drug binding | HIGH POTENCY | tubulin isotypes | TAXOID SITE | PACLITAXEL RESISTANCE | MULTIDISCIPLINARY SCIENCES | microtubule stabilizing agents | PELORUSIDE-A | DYNAMIC INSTABILITY | LINES | CELL LUNG-CANCER | photolabeling | III-TUBULIN | MUTATIONS | Biological Sciences
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 03/2018, Volume 38, Issue 3, pp. 1629 - 1635
Background/Aim: Class III beta-tubulin (TUBB3) expression is recognized as a predictive marker for chemosensitivity to cisplatin-and taxane-based... 
Class III beta-tubulin | Prognosis | Bladder cancer | Cisplatin | Paclitaxel | CELL LUNG-CANCER | paclitaxel | OVEREXPRESSION | ONCOLOGY | bladder cancer | ISOTYPE | ERCC1 | RECURRENCE | cisplatin | prognosis | CARCINOMA
Journal Article
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 03/2010, Volume 5, Issue 3, pp. 320 - 325
Journal Article
Lung Cancer, ISSN 0169-5002, 2008, Volume 64, Issue 3, pp. 326 - 333
Journal Article
Journal Article